Fast facts Multiple myeloma and plasma cell dyscrasias /
"Our understanding of multiple myeloma (MM) is growing at a formidable pace, particularly in terms of risk factors and potential drug targets. Minimal residual disease (MRD) negativity is set to become the new benchmark in treatment, and cytogenetic analysis is now paving the way for personaliz...
| Main Author: | |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
OXFORD :
HEALTH Press,
2017
|
| Series: | Fast facts
|
| Subjects: |